Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1985 1
1986 3
1987 4
1989 2
1990 3
1991 1
1992 3
1993 7
1994 8
1995 1
1996 10
1997 13
1998 28
1999 19
2000 16
2001 17
2002 30
2003 27
2004 40
2005 46
2006 46
2007 69
2008 90
2009 118
2010 129
2011 171
2012 207
2013 250
2014 270
2015 303
2016 313
2017 282
2018 390
2019 484
2020 521
2021 618
2022 470
Text availability
Article attribute
Article type
Publication date

Search Results

4,457 results
Results by year
Filters applied: . Clear all
Page 1
A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia.
An G, Zhou D, Cheng S, Zhou K, Li J, Zhou J, Xie L, Jin J, Zhong L, Yan L, Guo H, Du C, Zhong J, Yu Y, Wu B, Qiu L. An G, et al. Among authors: zhong l. Clin Cancer Res. 2021 Oct 15;27(20):5492-5501. doi: 10.1158/1078-0432.CCR-21-0539. Epub 2021 Jul 12. Clin Cancer Res. 2021. PMID: 34253577 Clinical Trial.
[Advances in bioremediation of hydrocarbon-contaminated soil].
Zhong L, Qing J, Chen H, Li G, Chen G, Sun Y, Li J, Song Y, Yan B. Zhong L, et al. Sheng Wu Gong Cheng Xue Bao. 2021 Oct 25;37(10):3636-3652. doi: 10.13345/j.cjb.210115. Sheng Wu Gong Cheng Xue Bao. 2021. PMID: 34708616 Free article. Review. Chinese.
4,457 results